Article Details
Retrieved on: 2024-06-27 16:47:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
GT Biopharma, Inc. announced FDA clearance of its IND application for GTB-3650, allowing the company to proceed with a Phase 1 clinical trial, ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here